Advertisement
Advertisement
RVMD
Revolution Medicines, Inc. Common Stock
190.35
USDSponsored
+2.23
+1.19%
Oct 09, 15:37 UTC -4
Open
RVMD Earnings Reports
Positive Surprise Ratio
RVMD beat 7 of 27 last estimates.
26%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$21.90M
/-$2.45
Implied change from Q2 26 (Revenue/ EPS)
--
/-19.93%
Implied change from Q3 25 (Revenue/ EPS)
--
/+52.17%
Revolution Medicines, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, RVMD reported earnings of -3.06 USD per share (EPS) for Q2 26, missing the estimate of -2.01 USD, resulting in a -51.69% surprise. Revenue reached --, compared to an expected 16.70 million, with a -100.00% difference. The market reacted with a +0.26% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 14 analysts forecast an EPS of -2.45 USD, with revenue projected to reach 21.90 million USD, implying an decrease of -19.93% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nanobiotix S.A. - ADR
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.70
Surprise
-496.76%
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
NeuroSense Therapeutics Ltd. Ordinary Shares
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$3.26
Actual
-$2.10
Surprise
+35.66%
FAQ
What were Revolution Medicines, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Revolution Medicines, Inc. Common Stock reported EPS of -$3.06, missing estimates by -51.69%, and revenue of $0.00, -100% below expectations.
How did the market react to Revolution Medicines, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 0.26%, changed from $197.30 before the earnings release to $197.81 the day after.
When is Revolution Medicines, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Revolution Medicines, Inc. Common Stock's next earnings report?
Based on 14
analysts, Revolution Medicines, Inc. Common Stock is expected to report EPS of -$2.45 and revenue of $21.90M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.